BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37242488)

  • 1. Development of Novel Small-Molecule Activators of Pyruvate Kinase Muscle Isozyme 2, PKM2, to Reduce Photoreceptor Apoptosis.
    Wubben TJ; Chaudhury S; Watch BT; Stuckey JA; Weh E; Fernando R; Goswami M; Pawar M; Rech JC; Besirli CG
    Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule activation of metabolic enzyme pyruvate kinase muscle isozyme 2, PKM2, circumvents photoreceptor apoptosis.
    Wubben TJ; Pawar M; Weh E; Smith A; Sajjakulnukit P; Zhang L; Dai L; Hager H; Pai MP; Lyssiotis CA; Besirli CG
    Sci Rep; 2020 Feb; 10(1):2990. PubMed ID: 32076076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoreceptor metabolic reprogramming provides survival advantage in acute stress while causing chronic degeneration.
    Wubben TJ; Pawar M; Smith A; Toolan K; Hager H; Besirli CG
    Sci Rep; 2017 Dec; 7(1):17863. PubMed ID: 29259242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate kinase M2 regulates photoreceptor structure, function, and viability.
    Rajala A; Wang Y; Brush RS; Tsantilas K; Jankowski CSR; Lindsay KJ; Linton JD; Hurley JB; Anderson RE; Rajala RVS
    Cell Death Dis; 2018 Feb; 9(2):240. PubMed ID: 29445082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and structure-guided fragment-linking of 4-(2,3-dichlorobenzoyl)-1-methyl-pyrrole-2-carboxamide as a pyruvate kinase M2 activator.
    Matsui Y; Yasumatsu I; Asahi T; Kitamura T; Kanai K; Ubukata O; Hayasaka H; Takaishi S; Hanzawa H; Katakura S
    Bioorg Med Chem; 2017 Jul; 25(13):3540-3546. PubMed ID: 28511909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyruvate Kinase 2, an Energy Metabolism Related Enzyme, May Have a Neuroprotective Function in Retinal Degeneration.
    Zhou J; Ekström P
    ASN Neuro; 2023; 15():17590914231151534. PubMed ID: 36799552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate kinase M2 isoform deletion in cone photoreceptors results in age-related cone degeneration.
    Rajala A; Wang Y; Soni K; Rajala RVS
    Cell Death Dis; 2018 Jul; 9(7):737. PubMed ID: 29970877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKM2 Is a Potential Diagnostic and Therapeutic Target for Retinitis Pigmentosa.
    Zhu P; Yang Q; Li G; Chang Q
    Dis Markers; 2021; 2021():1602797. PubMed ID: 34804260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol-17β upregulates pyruvate kinase M2 expression to coactivate estrogen receptor-α and to integrate metabolic reprogramming with the mitogenic response in endometrial cells.
    Salama SA; Mohammad MA; Diaz-Arrastia CR; Kamel MW; Kilic GS; Ndofor BT; Abdel-Baki MS; Theiler SK
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3790-9. PubMed ID: 24471565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Pyruvate Kinase M2 (PKM2) in Cardiovascular Diseases.
    Rihan M; Sharma SS
    J Cardiovasc Transl Res; 2023 Apr; 16(2):382-402. PubMed ID: 36178660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge-driven design and optimization of potent symmetric anticancer molecules: A case study on PKM2 activators.
    Jaiswal E; Globisch C; Jain A
    Comput Biol Med; 2022 Dec; 151(Pt B):106313. PubMed ID: 36450217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of boronic acid-based potent activators of tumor pyruvate kinase M2 and development of gastroretentive nanoformulation for oral dosing.
    Patle R; Shinde S; Patel S; Maheshwari R; Jariyal H; Srivastava A; Chauhan N; Globisch C; Jain A; Tekade RK; Shard A
    Bioorg Med Chem Lett; 2021 Jun; 42():128062. PubMed ID: 33901643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis.
    Anastasiou D; Yu Y; Israelsen WJ; Jiang JK; Boxer MB; Hong BS; Tempel W; Dimov S; Shen M; Jha A; Yang H; Mattaini KR; Metallo CM; Fiske BP; Courtney KD; Malstrom S; Khan TM; Kung C; Skoumbourdis AP; Veith H; Southall N; Walsh MJ; Brimacombe KR; Leister W; Lunt SY; Johnson ZR; Yen KE; Kunii K; Davidson SM; Christofk HR; Austin CP; Inglese J; Harris MH; Asara JM; Stephanopoulos G; Salituro FG; Jin S; Dang L; Auld DS; Park HW; Cantley LC; Thomas CJ; Vander Heiden MG
    Nat Chem Biol; 2012 Oct; 8(10):839-47. PubMed ID: 22922757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKM2 and cancer: The function of PKM2 beyond glycolysis.
    Dong G; Mao Q; Xia W; Xu Y; Wang J; Xu L; Jiang F
    Oncol Lett; 2016 Mar; 11(3):1980-1986. PubMed ID: 26998110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activity.
    Chen C; Wang T; Wu F; Huang W; He G; Ouyang L; Xiang M; Peng C; Jiang Q
    Drug Des Devel Ther; 2014; 8():1195-210. PubMed ID: 25214764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PKM2-dependent metabolic reprogramming in CD4
    Lü S; Deng J; Liu H; Liu B; Yang J; Miao Y; Li J; Wang N; Jiang C; Xu Q; Wang X; Feng J
    J Mol Med (Berl); 2018 Jun; 96(6):585-600. PubMed ID: 29732501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel 7-azaindole derivatives containing pyridin-3-ylmethyl dithiocarbamate moiety as potent PKM2 activators and PKM2 nucleus translocation inhibitors.
    Liu B; Yuan X; Xu B; Zhang H; Li R; Wang X; Ge Z; Li R
    Eur J Med Chem; 2019 May; 170():1-15. PubMed ID: 30878825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationalization of the activity Profile of Pyruvate Kinase Isozyme M2 (PKM2) Inhibitors using 3D QSAR.
    Kusuma M; Arora S; Kalra S; Chaturvedi A; Heuser M; Kumar R
    Curr Top Med Chem; 2021; 21(25):2258-2271. PubMed ID: 34348626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to the development of pulmonary arterial hypertension.
    Guo D; Gu J; Jiang H; Ahmed A; Zhang Z; Gu Y
    J Mol Cell Cardiol; 2016 Feb; 91():179-87. PubMed ID: 26774701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Specific Pyruvate Kinase M2 Inhibitor, Compound 3h, Induces Apoptosis and Autophagy through Suppressing Akt/mTOR Signaling Pathway in LNCaP Cells.
    Jiang C; Zhao X; Jeong T; Kang JY; Park JH; Kim IS; Kim HS
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.